A highly oncogenic strain of the lymphotropic tumour virus herpesvirus saimiri (HVS; strain 484-77) expresses four small RNAs (HSUR1 to 4) in high copy numbers in transformed T cells. In HSUR1 and HSUR2 the 5' terminal regions contain conserved AUUUA sequence repeats. The same AUUUA repeats occur in the 3' noncoding regions of growth factor, lymphokine and protooncogene mRNAs, and the sequence is involved in rapid mRNA degradation. We report here that by using a highly specific u.v. cross-linking method we identified a novel 70K binding factor with AUUUA sequence specificity. Non-radiolabelled competition and V8 protease analysis show that the protein can form a complex with the 3' non-coding region of interleukin-4 mRNA and bind the AUUUA repeats of a HVS small RNA. We also detected an AUUUA-specific minor 32K human protein with the same electrophoretic mobility as a marmoset factor implicated in growth factor mRNA destabilization. The findings are consistent with the hypothesis that the viral small RNAs can compete for factors involved in rapid degradation of growth factor mRNAs and may contribute to viral oncogenesis.
Introduction
Herpesvirus saimiri (HVS) is an oncogenic gammaherpesvirus, a close relative of Epstein-Barr virus (Gompels et al., 1988;  for review see Fleckenstein & Desrosiers, 1982) . In monkeys and rabbits the virus transforms CD8 + lymphocytes (Kiyotaki et al., 1986) and causes malignant lymphoproliferations (Daniel et al., 1974; Melendez et al., 1969) . Several data indicate that lymphokine and growth factor upregulation is involved in the process and mediate autocrine cell growth (Medveczky & Medveczky, 1989) . High-level interleukin (IL)-2 receptor expression (Medveczky & Medveczky, 1989) and IL-4 secretion was detected with transformed monkey cell lines (M. Medveczky, P. Geck, C.-S. Chou, A. Brown, J. Cus & P.G. Medveczky, unpublished results) and, in immortalized human CD4 + cell lines, upregulation of IL-3, IL-4, interferon-y, and tumour necrosis factor-~ and -fl were reported (De Carli et al., 1993) . Cell-cell contacts through CD2 and CD58 were also implicated in maintaining activation of transformed cells (Mittrucker et al., 1992) . Cytolytic and killer cell activities were detected with transformed human lymphocytes De Carli et al., 1993) .
To study molecular mechanisms in transformation by HVS, we focused on a highly oncogenic strain (484-77) and sequenced 6.2 kb of the oncogenicity-associated region. Five transcripts were identified and mapped: a 1"2 kb mRNA (Geck et al., 1990b) and four nuclear small RNAs, 120, 110, 81 and 64 nucleotides in length, termed HSUR1, -2, -3 and -4 respectively . The 1.2 kb mRNA has two open reading frames. The first (the analogue of STP-11, the HVS transforming protein in strain l l) codes for a polypeptide with a collagen-like domain (Geck et al., 1990b) . The protein was localized in intracellular membranes and in expression vectors the sequence can transform cells . The second open reading frame has also been shown to be involved in transformation by deletion analyses .
The four small RNAs and their genes have regulatory elements and other structural features that indicate a close relationship to cellular U-type small nuclear RNAs , as with small RNAs of other HVS strains (Lee et al., 1988) . The Y-terminal sequences of HSUR1 and HSUR2 are highly conserved and, in all three strains sequenced so far, AUUUA motifs occur repeatedly (Geck et al., 1990a) as shown in Fig. 1 .
A similar sequence with reiterated AUUUA motifs appears in the 3' non-coding mRNA regions of inducible growth regulatory proteins, growth factors and protooncogenes (for the IL-4 3' non-coding mRNA sequence see Methods; for a review of other sequences see Shaw & Kamen, 1986 extremely rapid turnover (Raj & Pitha, 1983; Greenberg et al., 1986; Ryseck et al., 1988 ), which appears to be regulated (Levine et al., 1986; Wilson & Treisman, 1988; Wodnar-Filipowitz & Moroni, 1990) . The 3' non-coding region and the AUUUA repeats were shown to signal rapid degradation (Caput et al., 1986; Shaw & Kamen, 1986; Vakalopoulou et al., 1991) . Elements involved in the regulation of mRNA turnover have already been reported: for example endo-and exonucleases (Ross et al., 1987; Jochum et al., 1990 ) and various binding proteins from different cells with AUUUA specificities, like the Auf protein from an erythroleukemoid line (Brewer, 1991) , the AU-A protein from T lymphocytes (Bohjanen et al., 1991) , the 32K protein from HeLa cells (Vakalopoulou et al., 1991) , a lymphokine mRNAspecific factor (AU-B) in stimulated T cells (Bohjanen et al., 1991) and the AUBF factor in unstimulated T cells (Malter & Hong, 1991) . A marmoset protein with similarities to the 32K HeLa cell protein was reported to bind some of the small RNAs of HVS strain 11 (Myer et al., 1992) . The finding that abundant viral small RNAs carry the key destabilization signals of growth factor mRNAs raised the intriguing possibility that their function may be related to mRNA turnover regulation (Geck et al., 1990a; Myer et al., 1992) . In theory, by competing for binding or degradation factors, the small transcripts could interfere with the regulation of mRNA destabilization. Stabilized mRNAs could command growth factor overexpression and so contribute to viral oncogenesis.
Our studies were designed to address a key element of the hypothesis, to find the link between the viral and mRNA sequences. By applying a novel RNA-protein signal transfer method, we searched for highly specific AUUUA binding factor(s) present in both the viral RNA-and mRNA protein complexes.
Methods
Tissue culture. Jurkat cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum and 10 p,g/ml gentamicin sulphate in 150 cm 3 flasks. Cells were harvested 6 to 12 h following addition of fresh medium.
Preparation of cellular extracts. Cells (5 × 107) were disrupted in 1 ml of modified lysis buffer (25 mM-Tris-HC1 pH 7"9, 0-5 mM-EDTA, 0.1 mM-phenylmethylsnlphonyl fluoride, 0.6 gM-aprotinin, 1 gMleupeptin and 1 mM-ATP) by freezing and thawing as described previously (Malter, 1989) .
Subcloning. All enzymatic and DNA manipulations were performed with standard procedures (Sambrook et al., 1989) and enzymes were obtained from Promega. The full-length HSUR2 coding sequence was generated by PCR using a 5' composite primer with the T3 RNA polymerase promoter sequence (in lower case), 5' aattaaccctcactaaagggagaACTCTACATATTTATTG 3'. The 3" primer used was 5' TCAACTATGTACACCCAG 3'. The product was blunt-ended by the Klenow fragment of DNA polymerase and cloned into the SmaI site of pUC19. To subclone the 3' non-coding AUUUA region from the human IL-4 cDNA (Yokota et al., 1986) an SspI site at position 530 and KpnI cleavage downstream in the polylinker generated a 256 bp fragment that contained the 3' non-coding region, the poly(A) region and a short polylinker from the vector. Bluescript II SK vector (Stratagene) was linearized with SaeIl, blunt-ended by the Klenow fragment, cut by KpnI and the isolated IL-4 cDNA fragment was inserted using T4 ligase. For a template to synthesize RNA with five repetitions of the AUUUA motif, the sense and antisense oligonucleotides were designed with the added upstream promoter for T3 RNA polymerase (lower case), the sense strand being 5' aattaaccctcactaaagggagaATTTATTTATTTATTTATTTA 3'. The two strands were annealed and cloned into the blunt-ended XbaI site of pUC 19. Sequence and polarity were confirmed by DNA sequencing in each case.
Oligonucleotide mutagenesis. A 2770 bp BamHI-HindlII fragment from the viral genome containing the gene for HSUR2 was cloned into the Bluescript II SK vector and ssDNA was prepared according to the manufacturer's instructions. A complementary oligonucleotide with two U to C mismatches (5' AAAGCAGCATTAATACATACAAT-ACATATGTAGAGTACAGC) was annealed to the template and extended and ligated by T4 DNA polymerase and ligase. After transformation, mutant clones were selected by colony hybridization using the mutant oligonucleotide as probe, and sequenced to confirm mutations. The mutant HSUR2 sequence was isolated by PCR and subcloned as described above.
In vitro transcription. To synthesize full-length viral small RNA, the HSUR2 recombinant plasmid was linearized by BamHI restriction endonuclease downstream of the HSUR sequence. For transcription of the 5' AU-rich region of HSUR2 (Fig. 1) , a DraI site was used, 36 nucleotides downstream from the 5' end. For IL-4 mRNA 3' noncoding sequence synthesis, the IL-4 construct was digested with HinfI at nucleotide position 611 of the cDNA sequence, generating a template of 82 nucleotides at the 3' non-coding region (5' attttaATTTAtgagtttttgatagctttattttttaagtATTTAtatATTTAtaactcatcataaaataaagtatataag 3'; the AUUUA coding sequence is in upper case). For transcription of the synthetic AUUUA pentamer sequence, the downstream polylinker Sall site was used for linearization to prepare a template of 27 nucleotides. The z2P-labelled RNAs were synthesized by T3 RNA polymerase as described (Melton et al., 1984) . The reaction mixture contained 30gM-[~2P]UTP (80gCi; NEN) and 700gM-unlabelled NTPs. The actual RNA probes contain four extra upstream nucleotides, due to promoter-internal initiation of T3 RNA polymerase.
Gel retardation assay.
In analytical binding reactions, 1 to 5 ng (3 x 104 c.p.m.) of RNA was incubated with cytoplasmic extracts in various amounts. We found that some modifications in published binding conditions (Malter, 1989) were necessary to enhance the resolution of minor bands. The extracts were preincubated with 400 units/ml of RNasin at 30 °C for 5 min and the binding reactions were incubated in 2.5 mM-HEPES pH 7"9, 3 mM-KC1, 0.05 mM-EDTA, 0-05 mM-dithiothreitol, 1 mM-MgC12, 400 units/ml RNasin, 2 gg of Escherichia coli tRNA and 10% glycerol at 34°C for 10min. Complexes were separated by electrophoresis at 70 V in 5% nondenaturing polyacrylamide gels with 0.25 x Tris b o r a t~E D T A running buffer.
U.v. cross-linking of RNA protein complexes and protein analysis'.
After preparative electrophoresis in 5% polyacrylamide gels (5 mm spacer), one glass plate was removed and the gel was u.v.-irradiated for 3 min using a Stratalinker device (Stratagene). After autoradiography for 5 to 30 minutes, complexes were cut out, electroeluted into BSAtreated dialysis membranes and incubated with RNase A (100 ~tg/ml) and RNase T1 (10 gg/ml) at 22 °C for 30 min. The preparations were boiled in SDS sample buffer (Sambrook et al., 1989) with 100 mM-2-mercaptoethanol before separation by 12% SDS-PAGE. To isolate individual polypeptides, preparative gels were processed as described above and the electroeluted proteins were subjected to partial V8 protease analysis (Cleveland et al., 1977) . We first determined whether the 5' end A U U U A region of the viral small RNA could bind proteins. As shown in Fig. 2 (a) , band-shift assays with the sequence revealed two major bands (complexes 3 and 4) and several minor bands (complexes 1, 2, 5 and 6) in standard binding conditions (Malter, 1989 ). An improved resolution of the same pattern is shown in Fig. 3 , where the modifications described in Methods were used.
Results

The viral small RNA and IL-4 mRNA sequences bind proteins and compete for protein complexes
To investigate growth factor-mRNA interactions, IL-4 was selected, since previous data from this and other laboratories indicated IL-4 upregulation in the autocrine growth of HVS-transformed tumour cells. The 3' noncoding region of IL-4 mRNA carries three A U U U A repeats (Yokota et al., 1986) in an arrangement typically found in destabilization signal sequences. Gel retardation experiments with an RNA probe representing the sequence displayed complex band-shift patterns (Fig.  2 b) , demonstrating that the IL-4 mRNA 3' non-coding region (for sequence see Methods) also complexes with proteins. . In (a), the viral sequence is labelled and the band-shift pattern is shown with 4 lal of extract (Binding) in conditions according to Malter (1989) . Unlabelled competitor RNAs (IL-4 3' non-coding sequence and E. coli tRNA) were added in 10-fold to 40-fold molar excesses as indicated. Positions of probe (RNA) and binding complexes (CI to C6) are indicated. In (b) the IL-4 m R N A sequence is radiolabelled and the band-shift pattern with 4 gl of extract is shown (Binding lane). Non-labelled competitor RNAs (viral small RNA 5' AU-rich sequence and E. coli tRNA) were mixed with the labelled transcript in 30-fold to 120-fold molar excesses as indicated and incubated with cell extracts. In the competition lanes, unbound probe did not reappear because the sequence rapidly degrades when it is not part of a protein complex, For the same reason the RNA control is shown in a separate lane. To investigate whether the viral and IL-4 RNA sequences can associate with common binding factors, non-radiolabelled competition experiments were carried out as shown in Fig. 2 . Both RNAs could compete with each other for binding complexes but the ranges of competing concentrations were different. Densitometric analyses indicated that a 10-fold molar excess of the IL-4 unlabelled RNA resulted in the same band intensity as an approximately 100-fold molar excess of the unlabelled H S U R A U U U A sequence. Taking the difference in probe sizes into account, complex formation by the IL-4 sequence appeared to be five times more efficient. This finding may partially reflect the difference in the number of A U U U A repeats (three in the IL-4 and two in the viral sequence) and indicates an overall higher binding affinity for the IL-4 3' non-coding region. In summary, the results suggest that the two RNAs compete for the same protein or protein complex.
P. Geck and others
Identification of A UUUA sequence-specific binding complexes
As a preliminary attempt to localize complexes where A U U U A specific protein(s) occur, we first determined whether bands in gel retardation patterns could be associated with AUUUA-specific binding. In theory, mutations in the viral A U U U A elements would abolish binding of factors specific to this motif and changes in band-shift patterns could identify the complex. Previous results with an array of mutations in the AU-B, AU-C, 32K and AUBF binding factors (Bohjanen et al., 1992; Caput et al., 1986; Gillis & Malter, 1991) showed that the A U G U A sequence was the most efficient in eliminating binding. In addition, replacing a U nucleotide with G did not affect RNase degradation in subsequent signal transfer experiments (see below), since RNase T1 is Gspecific. Therefore, A U U U A repeats in the viral sequence were changed to A U G U A by oligonucleotide-directed mutagenesis. Comparison of wild-type and mutant bandshift assays in Fig. 3 (a) showed that complex 4 of the wild-type pattern did not form with the mutant sequence and complex 5 and complex 6 were also greatly reduced.
The change of complex 4 in the mutant pattern suggested that this complex only forms when intact A U U U A repeats are present. However, alternative explanations, other than a change in binding protein composition, were not excluded (for example different conformation or degradation of the mutant probe). To investigate further the association of this complex with A U U U A repeats, an RNA with five repetitions of the A U U U A element was synthesized and radiolabelled. Comparison of band-shift patterns in Fig. 3 (b) demonstrates that the mobility of one complex with synthetic A U U U A repeats is identical to that of complex 4 of the wild-type viral sequence. Although identical mobilities do not directly indicate shared factors, these data represented strong circumstantial evidence that complex 4 might incorporate A U U U A sequence-associated component(s). Therefore, as a possible source from which to isolate AUUUA-specific proteins, we focused on complex 4 in subsequent studies.
Identification of A UUUA sequence-associated polypeptides in binding complexes
To characterize AUUUA-specific polypeptides in complexes, proteins were u.v.-cross-linked with radiolabelled RNA probes. Conventionally, u.v. cross-linking is performed with crude extracts in binding reactions. This method, however, is prone to non-specific signal transfer and degradation of RNA and proteins. We developed an alternative approach, where non-cross-linked complexes were electrophoretically separated first, immediately after brief incubation. Electrophoretic forces, running time and dilution in gel buffer allowed only highly specific proteins to remain RNA-associated and these were then u.v.-cross-linked in situ. After isolation and RNase A and T1 digestion, SDS-PAGE was performed.
First, we compared proteins of the viral wild-type complex 3 with wild-type complex 4 to investigate whether there were additional proteins in complex 4 compared to complex 3, because complex 4 appeared to contain A U U U A sequence-associated factor(s). Identical patterns were observed, with an additional 70K protein in complex 4, as shown in Fig. 4(a) . Since complex 3 formed with the mutant sequence, but complex 4 appeared only when intact A U U U A repeats were present, the result suggested that the 70K protein was probably involved in the association of complex 4 with the A U U U A repeat.
To confirm this role of the 70K polypeptide, protein patterns were also compared between the mutant and wild-type sequences (Fig. 4b) . The 70K protein was present in the wild-type complex but absent in the mutant pattern, and a minor 32K polypeptide also showed A U U U A specificity. In addition, a new protein band appeared at the 55K range with the mutant probe.
Complexes 5 and 6 were also isolated and their polypeptide patterns compared. As shown in Fig. 4(c) , the 70K factor is a major binding protein in the wild-type pattern and absent with the mutant probe in a similar way to the minor 32K protein. The 55K new band was also observed in the mutant pattern.
The appearance of the 55K protein raised the possibility that it might arise from the 70K factor. Different RNase degradation of the mutant probe may result in fewer u.v.-cross-linked nucleotides and that might affect electrophoretic mobility. The following considerations, however, argue against this possibility. Firstly, the difference in nucleotides cannot account for the 15K shift in protein mobility. Secondly, the original sequence and the mutant are equally susceptible to degradation by RNase A or T1. Thirdly, the amount of protein missing from the 70K bands should reappear in the 55K range, which was not observed. Consequently, the 55K protein is probably an A U G U A sequenceassociated factor and needs to be characterized in future studies.
To confirm the A U U U A specificity of the 70K protein, polypeptides complexing with the synthetic A U U U A repeats were compared with proteins binding to the 5' end region of HSUR2 (and also with those binding to the IL-4 3' non-coding A U U U A region; see below). Polypeptide patterns showed that the synthetic A U U U A repeats bind the 70K protein (Fig. 4d) . It should be noted that the actual M,. values of polypeptides may be somewhat different from the ones measured owing to nucleotide residue(s) being covalently linked to proteins after signal transfer.
The 70K protein can also complex with the IL-4 m R N A 3" non-coding region
To investigate whether the 70K protein can form a complex with the 3' non-coding region of IL-4 mRNA, polypeptides of complex 4 with the viral wild-type and IL-4 A U U U A regions were characterized. As shown in Fig. 4 (d) and Fig. 5 (a) , polypeptide patterns of viral and IL-4 RNA-binding proteins were similar, but not identical. A protein in the 70K electrophoretic mobility range, however, was consistently present in the IL-4 RNA-binding complex. In order to investigate whether the 70K polypeptides from the viral and IL-4 complexes were identical, the proteins were electroeluted from SDS-polyacrylamide gels and characterized by V8 protease analysis. The results in Fig. 5 (b) demonstrate that although the IL-4 RNA-associated polypeptide was somewhat degraded, the patterns of the 70K proteins from the viral and IL-4 RNA complexes were identical.
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D i s c u s s i o n
The results presented in this work on a small nuclear RNA (HSUR2) of HVS demonstrate that the conserved Y-terminal AU-rich region binds proteins with high specificity. We report a novel 70K binding factor and show that it is specific for the conserved A U U U A repeats in the viral sequence. Partial proteolytic analysis demonstrated that the same protein can complex with the IL-4 m R N A 3" non-coding region, which contains three A U U U A motifs. Non-radiolabelled competition experiments showed that the viral sequence competes with the IL-4 m R N A for binding, and indicated approximately fivefold higher affinity of the IL-4 m R N A sequence over the viral probe. We also observed a minor AUUUA-specific polypeptide in human lymphocyte extracts with the same electrophoretic mobility as a 32K marmoset protein reported to bind the viral sequence (Myer et al., 1992) and implicated in growth factor mRNA destabilization (Myer et al., 1992; Vakalopoulou et al., 1991) . The A U U U A repeats of the nuclear RNAs HSUR1 and HSUR2 are highly conserved in different strains of HVS, indicating a biologically important function for the sequence. In a search for this function we found that the same sequence motif occurs in the 3' end non-coding mRNA regions of growth factors and proto-oncogenes and functions as a destabilization signal. Recent data indicate that the instability of short half-life mRNAs is predetermined in the nucleus (Vakalopoulou et al., 1991) . The conserved A U U U A repeats tag mRNAs for immediate degradation in the nucleus, or when they enter the cytoplasm. In post-transcriptional regulation of growth factor expression, protein factors bind and protect these sequences from rapid decay.
Since the viral small RNAs are abundantly expressed in the nucleus (2 x 104/cell; Lee & Steitz, 1990) , we determined whether they could interact with factors engaged in the nuclear regulation of m R N A destabilization. The results of this report demonstrate that the viral A U U U A repeats can bind multiple factors from protein complexes associated with m R N A destabilization regions. The function of the 70K factor has yet to be determined, but it clearly establishes a novel link between the A U U U A motifs of H S U R RNAs and growth factor mRNA turnover regulation.
Involvement of two proteins (the 70K and 32K factors) reflects the complexity of the regulation that directs 7OK' A UUUA' factor in HVS small RNA complex 2299 mRNA stability (Schiavi et al., 1992) . Multiple proteins may represent the balance between protective and destabilizing forces. Consequently, viral small RNAs may stabilize mRNAs in two possible ways. They could sequester destabilizing factors, or they could activate protective factors. Destabilization factors can be directly nucleolytic. Our data do not rule out the possibility that the detected factor(s) are nucleases. The hallmarks of mRNA turnover-related ribonucleases are the requirement for a divalent cation and RNase inhibitor-resistant specific probe degradation (Ross et al., 1987; Wager & Assosian, 1990) . These were both observed with the protein reported here. In addition, u.v. crosslinking can identify endoribonucleases (D. C. Eichler, personal communication). It has yet to be determined whether nuclease activity is a direct function of the AUUUA binding factors.
Alternatively, if the identified proteins are protective factors, the viral U-type small RNAs may facilitate their transport to the nucleus. Primary transcripts of U-type RNAs are exported to the cytoplasm, where they complex with ribonucleoproteins and return to the nucleus (Zeller et al., 1983; Madore et al., 1984) . AUUUA elements of HSUR RNAs would take up AUUUA-binding factors in the cytoplasm and, by releasing them in the nucleus, the accumulation of protective factors could stabilize mRNAs. Notably, the IL-4 3' non-coding region exhibits fivefold higher affinity for binding than the viral 5' AU-rich region (Fig. 2) indicating that the IL-4 sequence could easily take up proteins from the HSUR complex. Further experiments are required to explore this alternative.
Although the mechanism of mRNA destabilization is not well understood, some factors have already been characterized. These proteins, however, are smaller in size than the 70K polypeptide and probably unrelated to this factor. On the other hand, several proteins in the 68K to 75K range have been shown to complex with primary transcripts or mRNAs. A 71K factor was reported to bind U-rich sequences (U-rich binding protein; URBP) in the c-fos mRNA 3' non-coding region (You et al., 1992) . This factor complexes with stretches of five to seven U residues implicated in poly(A) degradation but, unlike the protein of the present report, no binding was observed with AUUUA elements and mutations of the AUUUA motifs had no effect on binding.
Recent data indicate that mRNA destabilization is preceded by poly(A) decay (Brewer & Ross, 1988) under the regulation of the 3' non-coding mRNA region (Wilson & Treisman, 1988) . The poly(A) binding protein (PABP) is a 72K factor (Bernstein et al., 1989) , and one domain binds U-rich sequences (Burd et al., 1991) although no AUUUA sequence binding has been reported.
Several other proteins in the 70K Mr range are involved in mRNA processing and have poly(U) or polypyrimidine binding affinity [for example the 68K L hnRNP protein (Pinol-Roma et al., 1989) , the 70K intron binding protein or IBP (Gerke & Steitz, 1986; Tazi et al., 1986) , the 65K U2 auxiliary factor U2AF (Zamore & Green, 1991) and the 70K polypeptide of U1 snRNP (Theissen et al., 1986)] . No AUUUA binding has been reported with these proteins.
Although very little is known about the actual molecular mechanisms leading to HVS malignancy, circumstantial evidence also suggests that the viral small RNAs are involved in oncogenesis, and that growth factor mRNA stabilization may be part of the process. Expression of viral small RNAs is consistently observed in all HVS-transformed T cell lines and deletion experiments have demonstrated that the loss of HSUR1 and HSUR2 in strain 11 has a negative effect on cell proliferation (Murthy et al., 1989) . Preliminary data show that HSUR1 and HSUR2 deletion mutants of HVS strain 484-77 are non-oncogenic in New Zealand white rabbits. Changes in growth factor, growth factor receptor and lymphokine expression in HVS-transformed tumour cells have already been observed, although no solid evidence exists to relate them to HSUR expression.
In summary, this report further explores the possibility that HVS small RNAs have the potential to interfere with the transport, delivery or distribution of mRNA turnover regulatory factors in the nucleus and may ultimately contribute to viral oncogenesis. Characterization of the 70K factor, its function in mRNA stability, and its putative role in HVS transformation await further investigations.
